ACLARIS THERAPEUTICS INC. - COMMON STOCK
1.3600
03-مايو-24 15:59:59
15 متأخرة بدقائق
الأسهم
+0.0500
+3.82%
نطاق اليوم
1.3100 - 1.4000
ISIN
N/A
المصدر
NASDAQ
-
18 سبتمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
07 أغسطس 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
13 يونيو 2023 11:09:02 بحسب Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in Two June Healthcare Investor Conferences
02 يونيو 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports First Quarter 2023 Financial Results and Provides a Corporate Update
08 مايو 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Announce First Quarter 2023 Financial Results on May 8, 2023
02 مايو 2023 07:01:12 بحسب Nasdaq GlobeNewswire
-
27 مارس 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
06 مارس 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
23 فبراير 2023 07:00:01 بحسب Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in the Virtual SVB Securities Global Biopharma Conference
09 فبراير 2023 16:01:00 بحسب Nasdaq GlobeNewswire
-
Aclaris Therapeutics Provides 2023 Outlook
06 يناير 2023 07:01:00 بحسب Nasdaq GlobeNewswire
-
29 نوفمبر 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Aclaris Therapeutics Announces Key Leadership Transitions
22 نوفمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in Two November Healthcare Investor Conferences
10 نوفمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
08 نوفمبر 2022 07:00:03 بحسب Nasdaq GlobeNewswire
-
Aclaris Therapeutics Appoints Robert Doody as Vice President, Investor Relations
27 سبتمبر 2022 07:00:24 بحسب Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
30 أغسطس 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update
03 أغسطس 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Aclaris Therapeutics Expands Leadership Team
27 يونيو 2022 07:00:00 بحسب Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference
01 يونيو 2022 16:01:00 بحسب Nasdaq GlobeNewswire